Clincosm LogoSign in Get a demo

Triple Negative Breast Cancer

Showing NaN - NaN of 44
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Malignancy, Non-hodgkin Lymphoma, Multiple Myeloma Trial in United States (CYT-0851, CYT-0851 in combination with gemcitabine,

Recruiting
  • Malignancy
  • +14 more
  • Scottsdale, Arizona
  • +17 more
Mar 7, 2022

Ovarian Cancer, Head Neck Cancer, Non Small Cell Lung Cancer Trial in United States (TJ004309)

Recruiting
  • Ovarian Cancer
  • +5 more
  • Tucson, Arizona
  • +17 more
Jan 18, 2022

Advanced Cancer, Ovarian Cancer, Breast Cancer Trial in United States (COM701, COM701 with Opdivo (Nivolumab).)

Recruiting
  • Advanced Cancer
  • +9 more
  • COM701
  • COM701 with Opdivo (Nivolumab).
  • Los Angeles, California
  • +10 more
Jan 25, 2022

Solid Tumors, NSCLC, Urothelial Carcinoma Trial in Worldwide (GEN1046, GEN1046 in combination with docetaxel (in a single

Recruiting
  • Solid Tumors
  • +6 more
  • GEN1046
  • +2 more
  • Phoenix, Arizona
  • +40 more
Jan 14, 2022

Triple Negative Breast Cancer, TNBC - Triple-Negative Breast Cancer, Breast Cancer Trial in United States (Pembrolizumab,

Recruiting
  • Triple Negative Breast Cancer
  • +2 more
  • Basking Ridge, New Jersey
  • +6 more
Sep 15, 2021

Metastatic Breast Cancer, Triple Negative Breast Cancer Trial in United States (PMD-026)

Recruiting
  • Metastatic Breast Cancer
  • Triple Negative Breast Cancer
  • Gilbert, Arizona
  • +8 more
Aug 20, 2021

Comparison of the Breast Tumor Microenvironment

Recruiting
  • Triple Negative Breast Cancer
  • Hormone Receptor Positive Malignant Neoplasm of Breast
  • Breast tissue collection
  • Blood sample collection
  • New York, New York
    Columbia University Irving Medical Center
Aug 18, 2021

Gastric Adenocarcinoma, Esophageal Cancer, Hepatocellular Carcinoma Trial in United States (Sacituzumab Govitecan-hziy (SG))

Completed
Has Results
  • Gastric Adenocarcinoma
  • +15 more
  • Sacituzumab Govitecan-hziy (SG)
  • Aurora, Colorado
  • +11 more
Aug 10, 2021

Solid Tumor, Adult, Triple Negative Breast Cancer, Head and Neck Squamous Cell Carcinoma Trial in United States (AVID100 IV)

Terminated
  • Solid Tumor, Adult
  • +3 more
  • AVID100 IV
  • New Haven, Connecticut
  • +9 more
Mar 22, 2021

Triple Negative Breast Cancer Trial in Worldwide (Cyclophosphamide, Placebo, Doxorubicin)

Completed
  • Triple Negative Breast Cancer
  • Scottsdale, Arizona
  • +157 more
Jan 15, 2021

Triple Negative Breast Cancer Trial in Worldwide (Tivozanib Hydrochloride, paclitaxel, Placebo)

Terminated
Has Results
  • Triple Negative Breast Cancer
  • Tivozanib Hydrochloride
  • +2 more
  • Birmingham, Alabama
  • +53 more
Oct 5, 2020

Patient-derived Xenograft Modeling of Treatment Response for

Completed
  • Triple Negative Breast Cancer
  • Chemotherapy
  • New York, New York
    Dubin Breast Center of The Tisch Cancer Institute at Mount Sinai
Jul 1, 2020

Solid Tumor, Triple Negative Breast Cancer Trial in United States (RX-5902)

Terminated
  • Solid Tumor
  • Triple Negative Breast Cancer
  • Tucson, Arizona
  • +7 more
Jan 3, 2020

Cancer of the Breast, Breast Cancer, Advanced Breast Cancer Trial in United States (Seviteronel)

Completed
  • Cancer of the Breast
  • +6 more
  • Birmingham, Alabama
  • +35 more
Jan 31, 2019

Carcinoma, Renal Cell, Kidney Diseases, Kidney Tumors Trial in United States (Combination of Varlilumab and Atezolizumab)

Terminated
  • Carcinoma, Renal Cell
  • +13 more
  • Combination of Varlilumab and Atezolizumab
  • San Francisco, California
  • +3 more
Apr 26, 2018

Triple Negative Breast Cancer Trial in New York (Temsirolimus, Cisplatin, Erlotinib)

Completed
  • Triple Negative Breast Cancer
  • New York, New York
    Columbia University Medical Center
Dec 11, 2017

Breast Cancer, Triple Negative Breast Cancer, Stage IV Breast Cancer Trial in United States (Abraxane alone, Abraxane +

Completed
Has Results
  • Breast Cancer
  • +3 more
  • Abraxane alone
  • Abraxane + Tigatuzumab
  • Birmingham, Alabama
  • +9 more
Oct 24, 2017

Estrogen Receptor Negative Breast Cancer, Human Epidermal Growth Factor 2 Negative Carcinoma of Breast, Triple Negative Breast

Terminated
Has Results
  • Estrogen Receptor Negative Breast Cancer
  • +5 more
  • Birmingham, Alabama
  • +15 more
May 22, 2017

Breast Cancer, HER-2 Positive Breast Cancer, Triple Negative Breast Cancer Trial in Worldwide (ganetespib)

Completed
  • Breast Cancer
  • +3 more
  • Birmingham, Alabama
  • +24 more
Nov 4, 2015